Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : Japan to give 1 mln doses of vaccine each to Taiwan, Vietnam, says formin Motegi

06/24/2021 | 10:11pm EDT

TOKYO, June 25 (Reuters) - Japanese Foreign Minister Toshimitsu Motegi said on Friday that Japan will give 1 million additional doses of AstraZeneca COVID-19 vaccine each to Taiwan and Vietnam.

He added that arrangements were also being made to send 1 million doses each of AstraZeneca vaccine to Thailand, Malaysia, Indonesia and the Philippines. (Reporting by Nobuhiro Kubo, Writing by Elaine Lies; Editing by Jacqueline Wong)


ę Reuters 2021
All news about ASTRAZENECA PLC
08:38aASTRAZENECA : Japan to ship total of 1.6 mil. COVID vaccine doses to Nepal
AQ
03:10aThai hospital tycoon who promised Pfizer vaccine says deal now unlikely
RE
08/03ASTRAZENECA : Chilean study shows variations in success of COVID-19 vaccines
RE
08/03THE LATEST : NYC: Vaccination proof for indoor dining, gyms
AQ
08/03ASTRAZENECA : SAPHNELO approved in the US for moderate to severe systemic lupus ..
AQ
08/03ASTRAZENECA : Sanwo-Olu - Lagos Recorded 4,300 Cases, 30 Fatalities in July
AQ
08/03ASTRAZENECA : Covid-19 Third Wave - Lagos Records 42 Deaths in One Week - Sanwo-..
AQ
08/02Fancy a Covid jab? Here are all the free walk-in sites open in London
AQ
08/02U.S. Food and Drug Administration Approves AstraZeneca PLC's SaphneloÖ (Anifr..
CI
08/02SAPHNELO (Anifrolumab) Approved in the US for Moderate to Severe Systemic Lup..
CI
More news
Financials (USD)
Sales 2021 35 065 M - -
Net income 2021 5 236 M - -
Net Debt 2021 25 946 M - -
P/E ratio 2021 30,5x
Yield 2021 2,44%
Capitalization 179 B 179 B -
EV / Sales 2021 5,84x
EV / Sales 2022 4,76x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Last Close Price 115,47 $
Average target price 133,83 $
Spread / Average Target 15,9%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC13.29%178 598
JOHNSON & JOHNSON10.81%459 079
ROCHE HOLDING AG14.16%340 492
PFIZER, INC.24.10%255 703
ELI LILLY AND COMPANY51.62%232 701
NOVARTIS AG-0.20%224 638